Healthcare Services Group, Inc. Reports Q4 2022 Results

Rhea-AI Summary

Healthcare Services Group, Inc. (NASDAQ:HCSG) reported Q4 2022 revenue of $424.0 million and net income of $16.2 million, or $0.22 per share. Direct costs accounted for 86.5% of revenue, with notable margins in housekeeping & laundry (8.7%) and dining & nutrition (4.3%). The Board has suspended the quarterly cash dividend and authorized the repurchase of up to 7.5 million shares. Cash flow from operations was $22.9 million. Despite industry challenges, the company remains optimistic about growth due to its strong market position and operational efficiency, as stated by CEO Ted Wahl.

Positive

• Revenue of $424.0 million for Q4 2022.
• Net income of $16.2 million, translating to $0.22 per share.
• Suspension of quarterly cash dividend allows for better capital allocation.
• Repurchase authorization for up to 7.5 million shares enhances shareholder value.
• Achieved 2022 cost target of 86% for cost of services.

Negative

• Direct costs represented 86.5% of revenues, indicating high operational costs.
• Increased reserves for accounts receivable by $8.6 million, which may impact future liquidity.
• Ongoing industry headwinds such as workforce availability and inflation.

Achieves Direct Cost Target, Rebalances Capital Allocation Strategy

BENSALEM, Pa.--(BUSINESS WIRE)-- Healthcare Services Group, Inc. (NASDAQ:HCSG) (the “Company”) reported for the three months ended December 31, 2022 revenue of $424.0 million, net income of $16.2 million, or $0.22 per basic and diluted common share, and cash flow from operations of $22.9 million. The Company also announced that, as part of a comprehensive rebalancing of its capital allocation strategy, its Board of Directors has suspended the quarterly cash dividend on its common stock and authorized the repurchase of up to 7.5 million shares of its common stock.

Q4 Results

• Revenue for the quarter was reported at $424.0 million, with housekeeping & laundry and dining & nutrition segment revenues of $198.0 million and $226.0 million, respectively.
• Housekeeping & laundry and dining & nutrition segment margins were 8.7% and 4.3%, respectively.
• Direct cost of services was reported at $366.8 million, or 86.5%. Direct cost included a $9.8 million benefit related to favorable workers’ compensation loss development trends offset, in part, by an $8.6 million increase in AR reserves.
• Selling, general and administrative (“SG&A”) was reported at $39.5 million; after adjusting for the $2.1 million increase in deferred compensation, actual SG&A was $37.4 million, or 8.8%.
• The effective tax rate was 19.4% for the fourth quarter and 23.2% for full year 2022. The Company expects a 2023 tax rate of 24% to 26%.
• Cash flow from operations for the quarter was $22.9 million and was impacted by a $3.1 million decrease in accrued payroll, including the impact of the second half, or $24.4 million, of the deferred FICA payment. DSO for the quarter was 72 days.

Ted Wahl, Chief Executive Officer, stated, “I’m pleased with our fourth quarter results, which underscore the resilience of our business model and continued passion and perseverance of our people in a challenging operating environment. We achieved our 2022 goal of exiting the year with cost of services in line with our historical target of 86%, met our Q4 goal of ‘collecting what we bill,’ and have a growing pipeline of future client-partners as we head into 2023.”

Mr. Wahl continued, “While the industry continues to face headwinds related to workforce availability, inflation and supply chain constraints, we are encouraged by the gradual but steadily improving facility census and labor market trends. We will continue to closely monitor industry dynamics, and we remain confident that the growth outlook for the Company remains strong given our market leadership, efficient operating model and the attractive demographics.”

Capital Allocation

The Company, as part of its disciplined and balanced approach to managing capital, is rebalancing its capital allocation strategy to enhance financial flexibility, invest in organic and inorganic opportunities and accelerate value creation. As such, the Board of Directors has suspended the quarterly cash dividend on its common stock and authorized the repurchase of up to 7.5 million shares of its common stock.

Mr. Wahl stated, “The Board regularly reviews the Company’s capital allocation strategy to ensure it supports our goal of creating value for shareholders by delivering on our near-term operational objectives and our growth outlook. As we look at the current opportunities, we believe that rebalancing our approach to allocating capital - especially given the prolonged industry recovery, ongoing macroeconomic challenges and our strong liquidity position - will result in more proactive, impactful and enduring value creation in the coming years.”

Conference Call and Upcoming Events

The Company will host a conference call on Wednesday, February 15, 2023, at 8:30 a.m. Eastern Time to discuss its results for the three months ended December 31, 2022. The call may be accessed via phone at 1 (888) 330-3451, Conference ID: 4431380. The call will be simultaneously webcast under the “Events & Presentations” section of the Investor Relations page on the Company’s website, www.hcsg.com. A replay of the webcast will also be available on the website for one year following the date of the earnings call.

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

This release and any schedules incorporated by reference into it may contain forward-looking statements within the meaning of federal securities laws, which are not historical facts but rather are based on current expectations, estimates and projections about our business and industry, and our beliefs and assumptions. Words such as “believes,” “anticipates,” “plans,” “expects,” “estimates,” “will,” “goal,” and similar expressions are intended to identify forward-looking statements. The inclusion of forward-looking statements should not be regarded as a representation by us that any of our plans will be achieved. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Such forward-looking information is also subject to various risks and uncertainties. Such risks and uncertainties include, but are not limited to, risks arising from our providing services to the healthcare industry and primarily providers of long-term care; the impact of and future effects of the COVID-19 pandemic or other potential pandemics; having a significant portion of our consolidated revenues contributed by one customer during the year ended December 31, 2022; credit and collection risks associated with the healthcare industry; our claims experience related to workers’ compensation and general liability insurance (including any litigation claims, enforcement actions, regulatory actions and investigations arising from personal injury and loss of life related to COVID-19); the effects of changes in, or interpretations of laws and regulations governing the healthcare industry, our workforce and services provided, including state and local regulations pertaining to the taxability of our services and other labor-related matters such as minimum wage increases; the Company's expectations with respect to selling, general, and administrative expense; and the risk factors described in Part I of our Form 10-K for the fiscal year ended December 31, 2021 under “Government Regulation of Clients,” “Service Agreements and Collections,” and “Competition” and under Item 1A. “Risk Factors” in such Form 10-K.

These factors, in addition to delays in payments from customers and/or customers in bankruptcy, have resulted in, and could continue to result in, significant additional bad debts in the near future. Additionally, our operating results would be adversely affected by continued inflation particularly if increases in the costs of labor and labor-related costs, materials, supplies and equipment used in performing services (including the impact of potential tariffs and COVID-19) could not be passed on to our customers.

In addition, we believe that to improve our financial performance we must continue to obtain service agreements with new customers, retain and provide new services to existing customers, achieve modest price increases on current service agreements with existing customers and/or maintain internal cost reduction strategies at our various operational levels. Furthermore, we believe that our ability to sustain the internal development of managerial personnel is an important factor impacting future operating results and the successful execution of our projected growth strategies. There can be no assurance that we will be successful in that regard.

HEALTHCARE SERVICES GROUP, INC. CONSOLIDATED STATEMENTS OF INCOME (Unaudited) (in thousands, except per share data)
	For the Three Months Ended						For the Year Ended
	December 31,						December 31,
		2022			2021			2022			2021
Revenues	$	424,020		$	420,447		$	1,690,176		$	1,641,959
Operating costs and expenses:
Cost of services provided		366,810			377,230			1,496,336			1,415,082
Selling, general and administrative		39,524			44,290			140,344			173,108
Income from operations		17,686			(1,073	)		53,496			53,769
Other income, net:
Investment and other income (expense), net		2,372			2,760			(8,414	)		8,054
Income before income taxes		20,058			1,687			45,082			61,823
Income tax expense (benefit)		3,899			(418	)		10,452			15,960
Net income	$	16,159		$	2,105		$	34,630		$	45,863
Basic earnings per common share	$	0.22		$	0.03		$	0.47		$	0.61
Diluted earnings per common share	$	0.22		$	0.03		$	0.47		$	0.61
Basic weighted average number of common shares outstanding		74,342			74,318			74,336			74,816
Diluted weighted average number of common shares outstanding		74,367			74,342			74,351			74,962

HEALTHCARE SERVICES GROUP, INC. CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (in thousands)
	December 31, 2022			December 31, 2021
Cash and cash equivalents	$	26,279		$	70,794
Marketable securities, at fair value		95,200			114,396
Accounts and notes receivable, net		336,777			293,388
Other current assets		50,376			67,804
Total current assets		508,632			546,382
Property and equipment, net		22,975			28,102
Notes receivable - long-term		32,609			29,259
Goodwill		75,529			74,755
Other intangible assets, net		15,946			20,805
Deferred compensation funding		33,493			46,691
Other assets		29,150			31,535
Total Assets	$	718,334		$	777,529
Accrued insurance claims - current	$	23,166		$	24,310
Other current liabilities		155,453			166,815
Total current liabilities		178,619			191,125
Accrued insurance claims - long-term		65,541			65,084
Deferred compensation liability		33,764			46,888
Other non-current liabilities		14,238			21,755
Stockholders' equity		426,172			452,677
Total Liabilities and Stockholders' Equity	$	718,334		$	777,529

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20230215005331/en/

Theodore Wahl

President and Chief Executive Officer

Matthew J. McKee

Chief Communications Officer

215-639-4274

investor-relations@hcsgcorp.com

Source: Healthcare Services Group, Inc.

FAQ

What were the Q4 2022 financial results for HCSG?

HCSG reported Q4 2022 revenue of $424.0 million, net income of $16.2 million, and earnings of $0.22 per share.

Why did HCSG suspend its quarterly cash dividend?

HCSG suspended its quarterly cash dividend as part of a capital allocation strategy to enhance financial flexibility and invest in growth opportunities.

What is the share repurchase plan announced by HCSG?

HCSG's Board authorized the repurchase of up to 7.5 million shares of its common stock.

What challenges does HCSG face in the current market?

HCSG faces challenges related to workforce availability, inflation, and supply chain constraints.

What was the cash flow from operations for HCSG in Q4 2022?

Cash flow from operations for HCSG in Q4 2022 was $22.9 million.